Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Obesity Medicine
•
Primary Care
How do you decide whether to reinitiate a GLP-1 agonist after a patient has experienced acute pancreatitis while on this therapy?
Answer from: at Community Practice
Will not try it again, given the seriousness of the side effect, and in most cases, there are alternatives.
Sign In
or
Register
to read more
27578
Related Questions
Do you avoid the use of GLP-1 R agonist therapy for treatment of obesity in patients with known gastroparesis?
What strategies do you recommend to address the negative self-talk/internalized bias that patients carry about their own weight?
How do you discuss the role (if there is any) of frequently weighing yourself at home for patients who desire weight loss?
How do you discuss the importance of ongoing lifestyle-based interventions when starting a GLP-1 agonist for medically relevant obesity (i.e., with comorbid conditions)?
Do you recommend restarting GLP-1RA after bariatric surgery if they tolerated it before the surgery?
How do you decide which GLP-1s to prescribe for obesity?
How do you consider sending fungal studies in a patient with pneumonia?
How do you counsel patients struggling to decide if they wish to pursue an invasive diagnostic procedure to confirm a severe illness with poor prognosis and/or limited treatment options?
How do you decide between anticoagulation and observation for an incidentally detected subsegmental pulmonary embolism in elderly patients with a history of gastrointestinal bleeding?
How would you approach counseling an older patient with significant hearing loss and nonadherence to use of hearing aids?